Secukinumab provides improvements in health-related quality of life in patients with psoriatic arthritis, regardless of the time since diagnosis: pooled results from the Secukinumab phase 3 trial program

Author(s)
Strand, Vibeke
Fitzgerald, Oliver
Coates, Laura C
Walsh, Jessica A
Canete, Juan D
Nash, Peter
Davenport, Eric
Pricop, Luminita
Hustache, Gregory
Gilloteau, Isabelle
Yocolly, Aurore
Augustin, Matthias
Griffith University Author(s)
Year published
2019
Metadata
Show full item record
Conference Title
Annals of the Rheumatic Diseases
Volume
78
Issue
Suppl 2
DOI
Subject
Clinical sciences
Immunology
Science & Technology
Life Sciences & Biomedicine
Rheumatology
Publication URI
Collection